FBXW5 acts as a negative regulator of pathological cardiac hypertrophy by decreasing the TAK1 signaling to pro-hypertrophic members of the MAPK signaling pathway
Xuejun Hui, Fengjiao Hu, Jia Liu, Changhai Li, Yang Yang, Shangzhi Shu, Peipei Liu, Fan Wang, Shuyan Li
Topics & Concepts
Muscle hypertrophyPressure overloadPathologicalInternal medicinePhenylephrineEndocrinologySignal transductionMAPK/ERK pathwayBiologyCardiac function curveMedicineCell biologyCardiac hypertrophyHeart failureBlood pressureUbiquitin and proteasome pathwaysSignaling Pathways in DiseaseNF-κB Signaling Pathways